{"product_id":"sunpharma-value-chain-analysis","title":"Sun Pharma Industries Value Chain Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-List-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDive Deeper Into the Activities Behind the Analysis\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThis Sun Pharma Industries Value Chain Analysis helps you understand how the company creates value across support and primary activities in one clear framework. This page already shows a real preview of the actual analysis, so you can review the content and format before buying. Purchase the full version to get the complete ready-to-use report.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eupport Activities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Support-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFirm Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSun Pharmaceutical Industries Ltd. uses a centralized corporate setup to manage finance, legal, compliance, and quality across India and overseas units, which matters in a regulated pharma business. In FY2025, it reported revenue from operations of about ₹52,000 crore, so tight oversight supports scale across formulations and APIs. The same structure helps keep audit, regulatory, and product-quality controls aligned across 100+ markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Support-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHuman Resource Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSun Pharma Industries Ltd. relies on 40,000+ employees across R\u0026amp;D, plants, QA, and regulatory roles to keep FDA- and EMA-facing sites audit-ready. In FY2025, Sun Pharma posted about ₹52,000 crore in sales, so stable hiring, low attrition, and fast training directly support filing speed and uninterrupted output. One missed specialist can slow a batch release.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Support-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Support-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSun Pharmaceutical Industries Ltd. used FY2025 R\u0026amp;D to refine formulations and add new medicines, supporting long-term differentiation in a tightly regulated market. Its FY2025 R\u0026amp;D spend was about ₹44.9 billion, or roughly 8.6% of sales, backing launches in specialty and generics. That spend helps Sun Pharma move faster on complex products, where approval quality and execution matter most.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Support-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProcurement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSun Pharmaceutical Industries Ltd. buys APIs, intermediates, excipients, packaging, and equipment from a large supplier base, and that scale matters because FY2025 revenue was above ₹50,000 crore. Tight procurement lowers input swings, supports steady plant output, and helps keep both branded formulations and API operations supplied. It also matters in a business with FY2025 gross R\u0026amp;D spend near ₹3,900 crore, since supply disruption can delay launches and raise costs. Strong sourcing control gives Sun Pharmaceutical Industries Ltd. better cost discipline and less quality risk across its network.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Support-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Support-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSun Pharmaceutical Industries Ltd.’s support engine powers scale, speed, and supply control\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSun Pharmaceutical Industries Ltd.’s support activities are built for scale: centralized finance, legal, compliance, and quality control help run a ₹52,000 crore FY2025 business across 100+ markets. A 40,000+ employee base and ₹44.9 billion FY2025 R\u0026amp;D spend support faster filings, audit readiness, and new product launches. Procurement control lowers supply risk for APIs and packaging.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eFY2025\u003c\/th\u003e\n\u003cth\u003eKey support data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e₹52,000 crore\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e₹44.9 billion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEmployees\u003c\/td\u003e\n\u003ctd\u003e40,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\nExamines how Sun Pharma Industries creates value across support functions and core operating activities\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eEditable Excel File\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\nProvides a concise Sun Pharma Industries value chain snapshot to quickly identify pain points, support activities, and core value drivers.\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003erimary Activities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Primary-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInbound Logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSun Pharmaceutical Industries Ltd. manages inbound logistics with strict quality checks on APIs, intermediates, excipients, and packaging materials, plus supplier qualification and lot traceability before release to manufacturing. In FY2025, the business generated revenue above ₹52,000 crore, so even small incoming-material errors can hit scale fast.\u003c\/p\u003e\n\u003cp\u003eThis tight control reduces contamination, stock loss, and batch risk across a global supply base.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Primary-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOperations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSun Pharmaceutical Industries Ltd. turns APIs and raw materials into finished drugs through tightly controlled, validated plants, so batch quality and regulatory compliance directly shape supply reliability. In FY2025, Sun Pharmaceutical Industries Ltd. posted strong scale in a business built on regulated output, with over 40 manufacturing sites across India and global markets. Small process slips can trigger recalls, warning letters, or plant shutdowns, so operations is one of the biggest value drivers in its chain.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Primary-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Primary-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOutbound Logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSun Pharmaceutical Industries Ltd. ships finished medicines through distributors, hospitals, pharmacies, and export channels across more than 100 countries. In FY2025, revenue rose to about ₹52,050 crore, showing the scale that its warehousing and shipment planning must support. Tight inventory control helps avoid stock-outs, keep service levels high, and protect sales in core markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Primary-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarketing and Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIn FY25, Sun Pharmaceutical Industries Ltd. generated about ₹52,000 crore in revenue, and its marketing and sales engine turned approved products into demand through field teams, distributor ties, and country-specific channel plans. This matters most in prescriptions, where branded outreach supports India and global markets, including the U.S., and helps Sun Pharmaceutical Industries Ltd. keep scale in a market that is tightly regulated and doctor-led.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Primary-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eService\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSun Pharmaceutical Industries Ltd. backs its products with medical information, pharmacovigilance, complaint handling, and fast quality issue resolution. This service layer matters most in chronic therapies, where patients may stay on treatment for years, so trust and response speed directly affect adherence. In FY2025, that support function helped protect product quality and the brand across a large global portfolio.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMedical info supports prescribers.\u003c\/li\u003e\n\u003cli\u003ePharmacovigilance tracks safety signals.\u003c\/li\u003e\n\u003cli\u003eComplaint handling protects trust.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/VALUE-CHAIN-Content-Primary-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSun Pharma’s FY2025 global medicine engine: ₹52,050 crore revenue, 40+ sites, 100+ markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSun Pharmaceutical Industries Ltd. used FY2025 scale of about ₹52,050 crore revenue to run primary activities that kept medicines moving from plant to patient. Its operations, spread across 40+ sites, turned APIs into regulated finished drugs with tight quality control. It then shipped products to 100+ countries and used sales and medical support to protect demand and safety.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePrimary activity\u003c\/th\u003e\n\u003cth\u003eFY2025 fact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eOperations\u003c\/td\u003e\n\u003ctd\u003e40+ manufacturing sites\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e₹52,050 crore\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarkets\u003c\/td\u003e\n\u003ctd\u003e100+ countries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eSun Pharma Industries Reference Sources\u003c\/h2\u003e\n\u003cp\u003eThis is the actual Sun Pharma Industries Value Chain Analysis document you’ll receive upon purchase—no sample, no placeholders, just the real report. The preview below is taken directly from the full version, so what you see is what you get. After checkout, you’ll unlock the complete, detailed document in full.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Balanced Scorecard","offers":[{"title":"Default Title","offer_id":53669116117334,"sku":"sunpharma-value-chain-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1027\/3715\/0294\/files\/sunpharma-value-chain-analysis.webp?v=1778899611","url":"https:\/\/balancedscorecardexamples.com\/products\/sunpharma-value-chain-analysis","provider":"Balanced Scorecard","version":"1.0","type":"link"}